NLSP News and Press, NLS Pharmaceutics Ltd. From 06/20/24

2024-06-20 06:02:00 ET 3 Top Tips for Navigating Bull and Bear Penny Stocks Markets in 2024 Trading penny stocks in both bull and bear markets presents unique opportunities for investors seeking substantial returns. Understanding the dynamics of these markets is crucial to maximizing in...

A look at the top 10 most actives in the United States Reliance Global Group Inc. (RELI) rose 76.2% to $0.3911 on volume of 383,719,808 shares NLS Pharmaceutics Ltd. (NLSP) rose 82.1% to $0.2701 on volume of 302,290,803 shares NVIDIA Corporation (NVDA) rose 3.5% to $135.58 on volume of 28...

A look at the top 10 most actives in the United States NLS Pharmaceutics Ltd. (NLSP) rose 156.2% to $0.38 on volume of 125,047,059 shares Reliance Global Group Inc. (RELI) rose 210.8% to $0.69 on volume of 110,427,102 shares Mustang Bio Inc. (MBIO) rose 53.3% to $1.15 on volume of 87,727,...

ZURICH, SWITZERLAND / ACCESSWIRE / June 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced the publicatio...

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 28, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced promising ...

2024-05-24 17:25:21 ET More on NLS Pharmaceutics NLS Pharmaceutics receives Nasdaq staff delisting determination Financial information for NLS Pharmaceutics Read the full article on Seeking Alpha For further details see: NLS Pharmaceutics receives non-com...

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 24, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous...

Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...

NLS Pharmaceutics Ltd. (NLSP) is expected to report for quarter end 2023-12-31

2024-04-19 17:10:25 ET More on NLS Pharmaceutics Seeking Alpha’s Quant Rating on NLS Pharmaceutics Historical earnings data for NLS Pharmaceutics Financial information for NLS Pharmaceutics Read the full article on Seeking Alpha For further det...